secwatch.observer — SEC 8-K summary
======================================

Issuer:     Avantor, Inc. (AVTR)
CIK:        0001722482
Form:       8-K/A
Filed at:   2026-08-27T20:40:18+00:00
Accession:  0001628280-26-059273
Event type: leadership
Sentiment:  neutral
Materiality: 0.40
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Avantor EVP Bioscience & Medtech Benoit Gourdier to depart Oct 14, 2026
-----------------------------------------------------------------------

- Benoit Gourdier, EVP Bioscience and Medtech Products, will leave Avantor on October 14, 2026.
- Transition Agreement signed August 21, 2026 with subsidiary VWR International, LLC.
- He remains employed through October 14, 2026, supporting segment integration activities.
- Severance benefits under Executive Severance and Change in Control Plan if he stays and complies.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1722482/000162828026059273/0001628280-26-059273-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1722482/000162828026059273/avtr-20260417.htm
  HTML page:      https://secwatch.observer/filing/0001628280-26-059273

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer